
Global Nucleic Acid Isolation and Purification Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
8327
May 2023
167
PDF
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
“Global Nucleic Acid Isolation and Purification Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global nucleic acid isolation and purification market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global nucleic acid isolation and purification market report has been segmented on the basis of product, method, type, application, end user, and region.
Introduction:
Nucleic acid isolation and purification process is a method of the molecular biology techniques. Methods for purifying nucleic acids from cell extracts are often combinations of extraction/precipitation, chromatography, centrifugation, electrophoresis, etc. These techniques are widely used in the various verticals including life science research, genetic engineering, molecular diagnostics and forensics.
Market Dynamics:
Key factors expected to drive growth of the global nucleic acid isolation and purification market is increasing funding in the biopharmaceutical and healthcare sectors. In addition, rising healthcare expenditure, growing geriatric population, new technological advancement in genetic engineering sector, increasing use of nucleic acid-based tests in diagnosis of diseases are some other factors expected to drive growth of the global nucleic acid isolation and purification market. Furthermore, increasing investments from pharma companies, government initiatives for conducting R&D activities for nucleic acid isolation and purifications, growing demand for effective and minimal invasive treatments, growing incidence and prevelance rate of chronic diseases are some other factors expected to drive growth of the target market over the forecasted period. However, stringent regulatory rules and regulation are factors expected to hamper growth of the global nucleic acid isolation and purification market to a certain extent in the forecast period.
Trends:
Major players in the nucleic acid isolation and purification market are focusing on collaborating with other local players for expanding geographical footprints as well as to development and launch new technological advance products. For instance, in October 2017, Avalon GloboCare Corp. and GenExosome Technologies Inc., acquired 100% of the outstanding capital stock of a Chinese exosome technology company, called Beijing Jieteng GenExosome Biotech Co. Ltd. These are some of the trends witnessed in the target market, currently.
Regional Analysis:
The market in North America is expected to dominate the global nucleic acid isolation and purification market. This is primarily attributed to increasing use of kits for molecular diagnostics and government initiatives for funding R & D activities for development of novel therapeutic treatment procedure. In contrast, the market in Asia Pacific is expected to be an emerging market for the global nucleic acid isolation and purification market, and is expected to register highest CAGR in during the forecasted period, owing to increasing R&D spending in biotechnology and pharmaceutical companies, and technological advancements in country in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register moderate growth revenue in the global nucleic acid isolation and purification market over the forecast period.
GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION:
Segmentation by product:
- Kits
- Reagents
- Instruments
Segmentation by method:
- Column-based Isolation and Purification
- Reagent-based Isolation and Purification
- Magnetic Bead-based Isolation and Purification
- Other methods (solid phase isolation, inorganic isolation methods, etc.)
Segmentation by type:
- Plasmid DNA Isolation and Purification
- Total RNA Isolation and Purification
- Genomic DNA Isolation and Purification
- Messenger RNA Isolation and Purification
- Micro RNA Isolation and Purification
- Circulating nucleic acid Isolation and Purification
- PCR Cleanup
- Other type
Segmentation by application:
- Diagnostics
- Drug Discovery and Development
- Precision Medicine
- Agriculture & Animal Research
- Other applications
Segmentation by end user:
- Research Centers and Academic
- Hospitals and Clinics
- Pharmaceutical & Biotechnology Companies
Segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - QIAGEN
- Thermo Fisher Scientific, Inc.
- Hoffmann-La Roche AG
- Merck KGaA
- Bio-Rad Laboratories
- Agilent technologies Inc.
- Illumina, Inc.
- Takara Bio Inc.
- New England Biolabs
- Promega Corporation
- General Electric Company
- Danaher Corporation
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!